From: Levels of S100B are raised in female patients with schizophrenia
Demographic data | Patient group | Control group |
---|---|---|
Subjects (Male:Famale) | 97 (68:29) | 27 (10:17) |
Age (Range) (yrs) | 42.5 ± 12.2 (22–78) | 42.4 ± 10.3 (25–57) |
Treatment duration (Range) (Yrs) | 6.99 ± 4.64 (0.25-19) | n/a |
Daily dose (Range) (mg/day) | 432.1 ± 185.7 (125–900) | n/a |
BPRS (18–126) | 31 ± 9 | n/a |
SAN (0–125) | 34 ± 18 | n/a |